GLMD
Galmed Pharmaceuticals Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$3.88
−1.02%Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- -0.23x
- Debt / assets
- 0.01x
- Debt / EBITDA
- -0.01x
- Net debt / EBITDA
- 0.25x
Liquidity & coverage
- Current ratio
- 4.16x
- Quick ratio
- 4.16x
- Cash ratio
- 4.05x
- Interest coverage
- -97.61x
- EBITDA / interest
- -113.03x
- Working capital
- $8.9M
Cash & dividend
- FCF / debt
- -66.22x
- Cash flow / debt
- -66.22x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026